PUrsuing Novel Stem-Cell Derived Therapy For Lou Gehrig’s Disease With $10.8 Million Award
The Salk Institute has been awarded a $10.8 million grant by the California Institute for Regenerative Medicine (CIRM) for translational research focusing on developing a novel stem-cell based therapy for Amyotrophic Lateral Sclerosis (ALS) – or Lou Gehrig’s Disease. Sam Pfaff, Ph.D.
[Read the full article here]Related News:
Scientist Receives $10.8 Million Award to Develop Novel Stem-Cell Derived Therapy for Lou Gehrig’s Disease
CIRM awards Salk Institute $10.8M grant to develop stem-cell based therapy for Lou Gehrig’s Disease
UCSD team gets $11.5 million for stem cell research on Lou Gehrig’s disease